Immunology Company Kira Biotech launches with A$20M Series A Funding
Related Articles
-
Dreadlocks anyone?
Cristian Silveira donates money raised to Dendritic Cell Research Cristian Silveira had been growing his hair for about 17...
-
Editor’s Desk: The Appeal Starts Here
Featured in Burwood Scene, July 3, 2013. I met Professor Derek Hart at Concord hospital eight months ago when...
-
ANZAC Research Institute Medical Appeal
Launch Speech by Burwood Scene Editor Belinda Noonan on 29 May 2013. I met Professor Derek Hart at Concord...
-
Global leader predicted for medical research
Featured in Burwood Scene, June 18, 2014. TREASURER Joe Hockey has declared that Australia will become a global leader...
-
Anti-cancer vaccine within reach
Featured in Burwood Scene, August 28, 2012. EXCLUSIVE: A 20-strong team of medical researchers led by Professor Derek Hart...
-
Gardens, Transplants and Collaborations
Dr Xinsheng Ju talks about his recent attendance at the 2015 Transplantation Science Symposium (TSS 2015) TSS 2015 was...
-
The cell treatment changing the lives of those living with Glioblastoma
Professor Derek Hart leading Australian research in Dendritic Immunotherapy. Broadcast on Today Tonight Thursday 1 October 2015.
-
Cancer vaccine closer
Featured in Burwood Scene, March 13, 2013. An anti-cancer vaccine is another step closer as the 20-strong team led...
![](mailto:?subject=Immunology Company Kira Biotech launches with A$20M Series A Funding&body=
<img class="aligncenter wp-image-3224 size-medium" src="http://dcresearch.org.au/wp-content/uploads/2019/10/Kira-Biotech-logo-300x150.jpg" alt="" width="300" height="150" /><br />
Brisbane, 29 October 2019: Kira Biotech today announced it has secured Series A funding of A$20 million to develop therapeutics targeting difficult-to-treat immune system disorders.
The round was led by OneVentures, with significant investment from IP Group and support from the Advance Queensland Business Development Fund. The funds will help advance Kira Biotech’s lead candidate KB312 through phase 1 human studies. <a style="color: #ffcc00;" href="https://kirabiotech.com/wp-content/uploads/2019/10/20191024-Kira-Biotech-Series-A-funding-press-release.pdf">Read More</a>
http://dcresearch.org.au/immunology-company-kira-biotech-launches-with-a20m-series-a-funding/){kind=link}